Search for: "Bayer Corp" Results 441 - 460 of 505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Feb 2014, 7:39 am by Kristen E. Polovoy
Bayer Corp., 727 F.3d 300 (3d Cir. 2013)), how would courts reconcile this federal law ascertainability requirement in Cortina-type 4-MeI cases in jurisdictions that provide for fluid recovery under state rules (e.g., New Jersey Rule 4:32-2(c))? [read post]
6 Jan 2017, 7:17 am by Charles Casper
Bayer Corp., 727 F.3d 300 (3d Cir. 2013), the Third Circuit added a second prong to the ascertainability requirement—that there must be “a reliable and administratively feasible” method for ascertaining proposed class members,  Carrera, 727 F.3d at 308, so they can be notified of their right to opt out, fraudulent claims can be policed, and defendants may exercise their due process right to challenge the proof used to demonstrate class membership. [read post]
2 Sep 2011, 3:43 am by Andrew J. Trask
Bayer Corp. held that denial of class certification does not preclude bringing another class action on the same facts. [read post]
2 Jul 2012, 7:21 pm by Eric Schweibenz
By way of background, the Complainant in this investigation is Eastman Kodak Company (“Kodak”) and the Respondents are Research in Motion, Ltd. and Research in Motion Corp. [read post]
13 Aug 2009, 12:10 pm
"); Bayer Aktiengesellschaft v. [read post]
6 Dec 2011, 3:30 am
Bayer Corp., 610 F.3d 390, 393-95 (7th Cir. 2010) and Tanoh v. [read post]
6 Dec 2011, 3:30 am
Bayer Corp., 610 F.3d 390, 393-95 (7th Cir. 2010) and Tanoh v. [read post]
28 Jun 2011, 11:30 pm by Jonathan H. Adler
Bayer rejected a corporation’s effort to preclude class actions in state court after prevailing against a class organized by different plaintiffs in federal court. [read post]
2 Jun 2011, 3:42 am by Russell Jackson
Bayer Corp. will impose constitutional limits on barring absent class members from filing other class actions in a way that might impact this Pampers settlement. [read post]
29 Jan 2010, 1:25 am
Cir. 2008) (quoting Pharmacia Corp. v. [read post]
1 Mar 2013, 2:30 pm by Bexis
Brown & Williamson Tobacco Corp., 938 A.2d 417 (Pa. 2007) (3-2 decision with two concurrences in the result), was not even cited in Maya. [read post]
1 May 2014, 4:59 am
  At most, Teva could have sought assistance from the FDA in convincing Bayer to adopt a stronger label for Yaz so it could do the same with regard to Gianvi. [read post]
27 Feb 2015, 4:58 am
Bayer Corp., 727 F.3d 300 (3d Cir. 2013), which we discussed here and slotted at #4 on our 2013 top ten list. [read post]